In the last two years the number of exists has fallen by 40 per cent and the total amount of VC funding is down 50 per cent, according to new research by NESTA.
SV Life Sciences has announced the final closing of its newest fund, SV Life Sciences Fund V, at over $523 million, well exceeding its target of $400 million.
German entrepreneur Lars Hinrichs has a new, off-the-peg approach to incubating start-ups. Could this plug the yawning gap in Europe’s venture capital system?
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.